Skip to main content
Physician wearing mask and face shield

EKOS™ Endovascular System

Treat the patient, not just the clot

This is why we EKOS.

 

Take action against pulmonary embolism

Backed by a decade of clinical evidence and the only level 1, Long-Term and Quality of Life data in the space, EKOS has been the interventional treatment of choice for patients with pulmonary embolism. 

No other device used to treat pulmonary embolism has been studied as much as EKOS. It's a low risk, and minimally invasive, 15-minute procedure.

EKOS catheter

EKOS+ catheter

With 50% more ultrasound power, the new EKOS+ catheter builds on the EKOS legacy and provides physicians more confidence to efficiently treat PE patients with lower lytic doses.  

Close-up of EKOS Endovascular System catheter, with ultrasonic pulses emanating from it.

Proven history and technology

When it comes to treatment of acute pulmonary embolism, EKOS is the undisputed leader. This reliable procedure offers immediate results—and positive long-term outcomes.

Blood platelets forming clot.

Clinical evidence

With 14 clinical trials published and more than 90,000 PE patients treated*, EKOS offers years of proven success.

Older patient looking directly at the camera. Older patient looking directly at the camera

Case studies

Lasting clinical results. Meaningful improvements. EKOS is a reliable, predictable procedure with proven outcomes.


icon of open envelope with letter

Stay up to date

Receive emails on the latest advances, EKOS clinical data and news.

References:
* Data on file.